Literature DB >> 3565926

The "horse-racing effect" and predicting decline in forced expiratory volume in one second from screening spirometry.

B Burrows, R J Knudson, A E Camilli, S K Lyle, M D Lebowitz.   

Abstract

Longitudinal spirometric data on adults in a general population sample confirmed an overall relationship between rate of change in FEV1 (delta FEV1) and mean FEV1/Ht3. This relationship between FEV1 "slope" and "level" has been called a "horse-racing effect" and is the basis for the widely accepted concept that detecting a low FEV1 will predict a rapid decline in FEV1 and the development of clinically significant COPD. However, when both age and smoking habits were taken into account, the effect persisted only in male smokers. Even in them, it was dependent on the inclusion of part of the delta FEV1 in calculation of the mean FEV1 value. While neither a low initial FEV1/Ht3 nor percent predicted FEV1 significantly predicted a subsequent rapid fall in FEV1, presumably because of regression toward the mean, other initial spirometric variables proved better predictors, at least among male smokers. In them, a low FEV1/FVC ratio on entry was almost uniformly associated with a high rate of decline in FEV1. This was not seen in ex-smokers with similar initial spirometric findings. Also, delta FEV1 could not be predicted with any precision in women regardless of their smoking status. The findings strongly support the concept that detection of early airway disease by spirometric screening will identify those male smokers who are likely to develop clinically significant illness if they continue to smoke and that smoking cessation, even at this point, can markedly improve the prognosis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1987        PMID: 3565926     DOI: 10.1164/arrd.1987.135.4.788

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  33 in total

1.  Peak expiratory flow as a surrogate for health related quality of life in chronic obstructive pulmonary disease: a preliminary cross sectional study.

Authors:  D O Obaseki; M O Akanbi; C C Onyedum; O B Ozoh; J Jumbo; A A Akor; G E Erhabor
Journal:  Ghana Med J       Date:  2014-06

2.  Interpretation of pulmonary function test: issues and controversies.

Authors:  Cristine E Berry; Robert A Wise
Journal:  Clin Rev Allergy Immunol       Date:  2009-03-21       Impact factor: 8.667

3.  Longitudinal decline in lung function in patients with occupational asthma due to western red cedar.

Authors:  F J Lin; H Dimich-Ward; M Chan-Yeung
Journal:  Occup Environ Med       Date:  1996-11       Impact factor: 4.402

4.  Dust exposure, respiratory symptoms, and longitudinal decline of lung function in young coal miners.

Authors:  P Carta; G Aru; M T Barbieri; G Avataneo; D Casula
Journal:  Occup Environ Med       Date:  1996-05       Impact factor: 4.402

5.  CHRONIC OBSTRUCTIVE PULMONARY DISEASE-CURRENT STATUS AND MANAGEMENT.

Authors:  S K Jindal
Journal:  Med J Armed Forces India       Date:  2017-06-10

Review 6.  The epidemiological importance of intraindividual changes in objective pulmonary responses.

Authors:  M D Lebowitz; J Quackenboss; A E Camilli; D Bronnimann; C J Holberg; B Boyer
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

7.  Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study.

Authors:  Debra A Stern; Wayne J Morgan; Anne L Wright; Stefano Guerra; Fernando D Martinez
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

8.  Developing COPD: a 25 year follow up study of the general population.

Authors:  A Løkke; P Lange; H Scharling; P Fabricius; J Vestbo
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

Review 9.  The history of COPD.

Authors:  Thomas L Petty
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 10.  Palliative management of refractory dyspnea in COPD.

Authors:  Hope E Uronis; David C Currow; Amy P Abernethy
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.